货号:A217175
同义名:
SKF-108566J;Eprosartan (mesylate)
Eprosartan mesylate是一种选择性、竞争性和具有口服活性的血管紧张素 II 受体拮抗剂,可用作降压剂,在大鼠和人类肾上腺皮质膜中的 IC50 值分别为 9.2 nM 和 3.9 nM。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
靶点 |
|
描述 | Angiotensin receptor is a G protein coupled receptor with angiotensin as ligand, which can trigger various signal cascades after being activated. Eprosartan mesylate (SKF-108566J) is a nonpeptide angiotensin receptor antagonist[3]. In rat and human adrenal cortical membranes, rat mesenteric artery membranes and human liver membranes, Eprosartan Mesylate specifically displaced angiotensin receptor ligand, [125I] angiotensin II (AII), with IC50 of 9.2, 3.9, 1.5 and 1.7 nM, respectively[3]. In rabbit aortic smooth muscle cells, Eprosartan Mesylate caused a concentration-dependent inhibition of AII-induced increases in intracellular Ca2+ levels[3]. In vivo assay, administration of Eprosartan mesylate (3-10 mg/kg) intraduodenally or intragastrically to conscious normotensive rats resulted in a dose-dependent inhibition of the pressor response to AII (250 ng/kg, i.v.). At 10 mg/kg, i.d., significant inhibition of the pressor response to AII was observed for 3 hr[3]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01715584 | Hypertension | Phase 4 | Recruiting | December 31, 2019 | Canada, Ontario ... 展开 >> London Health Sciences Centre - Victoria Campus Recruiting London, Ontario, Canada, N6A 5W9 Contact: Craig J Railton, MD, PhD 519 685 8500 ext 58525 Craig.Railton@lhsc.on.ca Principal Investigator: Craig J Railton, MD, PhD Sub-Investigator: Jonathan Fairbairn, BSc Sub-Investigator: George Nicoloau, MD Sub-Investigator: Robert Gros, PhD Sub-Investigator: Jason Franklin, MD Sub-Investigator: John Yoo, MD Sub-Investigator: Kevin Fung, MD Sub-Investigator: Anthony Nichols, MD Sub-Investigator: Danielle McNeil, MD 收起 << |
NCT02024100 | - | Unknown | December 2016 | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Recruiting Seongnam-si, Bundang-gu, Korea, Republic of, 463-717 Contact: Chang Hwan Yoon, MD Principal Investigator: Chang Hwan Yoon, MD 收起 << | |
NCT01753206 | - | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Seongnam-si, Bundang-gu, Korea, Republic of, 463-717 收起 << | |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.92mL 0.38mL 0.19mL |
9.60mL 1.92mL 0.96mL |
19.21mL 3.84mL 1.92mL |
CAS号 | 144143-96-4 |
分子式 | C24H28N2O7S2 |
分子量 | 520.618 |
别名 | SKF-108566J;Eprosartan (mesylate);SKF-108566;SK and F 108566;Regulaten;Navixen;Futuran;Teveten |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,Room Temperature |
溶解方案 |
DMSO: 50 mg/mL(96.04 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |